TrialBritish journal of clinical pharmacology2013

The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis.

Bart J F van den Bemt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.